NKTR | Nektar Therapeutics
Category: Consumer goods
Quick infos Headquarters: San Francisco, California, United States Trade prices Volume: Market Cap: 698.53M Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: No Dividends Next ER: May 9, 2023 After Market Closes
Earnings History Date EPS / Forecast Revenue / Forecast August 10, 2023 May 9, 2023 0.73 / -0.2421.6M / 20.11MBeat! February 28, 2023 -0.32 / -0.451922.02M / 22.14MNovember 3, 2022 -0.31 / -0.44923.63M / 22.61MBeat! August 4, 2022 -0.85 / -0.9721.59M / 22.62Mview more
Historical Data Date Price Open High Low Vol Change ER May 9, 2023 0.77 0.74 0.78
0.73
3.0M 0% May 8, 2023 0.77 0.79 0.81
0.72
1.9M -6.1% May 5, 2023 0.82 0.79 0.84
0.78
1.3M 3.80% May 4, 2023 0.79 0.76 0.82
0.75
2.9M -1.25% May 3, 2023 0.8 0.75 0.85
0.75
2.4M 5.26% May 2, 2023 0.76 0.76 0.78
0.72
1.5M -1.3% May 1, 2023 0.77 0.75 0.78
0.74
1.5M 2.67% Apr 28, 2023 0.75 0.76 0.81
0.73
2.2M -5.06% Apr 27, 2023 0.79 0.8 0.82
0.77
1.7M -1.25% Apr 26, 2023 0.8 0.78 0.82
0.77
2.4M 2.56% view more
News
Nektar to cut over 500 jobs following cancer drug failure finance.yahoo.com Feb 27, 2023 5:57 pm
Nektar Therapeutics Announces Phase 2 Topline Data for Rezpegaldesleukin in Patients with Systemic Lupus Erythematosus finance.yahoo.com Feb 27, 2023 4:30 pm
Nektar Therapeutics Reports Second Quarter 2022 Financial Results finance.yahoo.com Feb 27, 2023 4:15 pm Why Nektar Therapeutics Stock Is Crashing Today fool.com Feb 27, 2023 11:30 am
Nektar Therapeutics Stock Tanks on More Failed Trials of Its Cancer Drug Bempeg barrons.com Feb 27, 2023 9:48 am Nektar to reduce workforce by 70% marketwatch.com Feb 27, 2023 8:53 am Why a S.F. biotech and its potential merger partner pulled the plug on talks bizjournals.com Oct 11, 2022 5:13 pm After a record-breaking decade, biotech is discovering what hard times feel like bizjournals.com May 27, 2022 8:00 am Why Nektar Therapeutics Stock Is Imploding Today fool.com Apr 18, 2022 12:01 pm
PureTech Health Confirms 'Possible' Merger With Nektar Therapeutics finance.yahoo.com Feb 27, 2023 11:21 am
Analysts Are Downgrading These 10 Pharmaceutical Stocks finance.yahoo.com Feb 27, 2023 9:17 am
Nektar Therapeutics Third Quarter 2022 Earnings: Beats Expectations finance.yahoo.com Feb 27, 2023 7:58 am
Why Nektar Therapeutics Stock Is Plunging Today finance.yahoo.com Feb 24, 2023 10:23 am
UPDATE 1-Nektar Therapeutics' autoimmune disease drug fails mid-stage study finance.yahoo.com Feb 23, 2023 6:20 pm
Nektar Therapeutics' President and CEO, Howard Robin, To Present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA finance.yahoo.com Jan 4, 2023 9:00 am
Nektar Therapeutics to Host Investor & Analyst Event on December 12th finance.yahoo.com Dec 5, 2022 8:00 am
Nektar's (NKTR) Q3 Earnings and Revenues Beat Estimates finance.yahoo.com Nov 4, 2022 12:35 pm
ImmunoGen (IMGN) Expected to Beat Earnings Estimates: Should You Buy? finance.yahoo.com Oct 28, 2022 10:00 am
Nektar to Announce Financial Results for the Third Quarter 2022 on Thursday, November 3, 2022, After Close of U.S.-Based Financial Markets finance.yahoo.com Oct 25, 2022 6:00 pm
Nektar Therapeutics (NASDAQ:NKTR shareholders incur further losses as stock declines 11% this week, taking five-year losses to 75% finance.yahoo.com Aug 21, 2022 9:57 am This company doesn't provide a dividend.
Talk about Nektar Therapeutics below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 50 HOLD 50 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.